☆ 4.7 Article

COVID-19 Mortality in Vaccinated vs. Unvaccinated Liver & Kidney Transplant Recipients: A Single-Center United States Propensity Score Matching Study on Historical Data

VACCINES (2022)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Population antibody responses following COVID-19 vaccination in 212,102 individuals

Helen Ward et al.

Summary: Population antibody surveillance is crucial for tracking immune responses to COVID-19 vaccinations. The study found that antibody positivity peaks 4-5 weeks after the first dose of the vaccine and then declines. Age, gender, comorbidities, and infection history affect antibody positivity rates.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Immunology

Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study

Victoria G. Hall et al.

Summary: This study examines the outcomes and severity of COVID-19 infection in solid organ transplant recipients who have been vaccinated. The findings suggest that vaccinated patients who develop breakthrough infections have similar disease severity to unvaccinated patients. This highlights the importance of alternative strategies for this population, considering the need for multiple vaccine doses in SOT recipients.

TRANSPLANTATION (2022)

Add to Collection

Letter Immunology

Trends in COVID-19 Mortality Among Solid Organ Transplant Recipients: Implications for Prevention

Kenji Okumura et al.

TRANSPLANTATION (2022)

Add to Collection

Article Immunology

COVID-19 Mortality in Vaccinated vs. Unvaccinated Liver & Kidney Transplant Recipients: A Single-Center United States Propensity Score Matching Study on Historical Data

Hailey Hardgrave et al.

Summary: This study analyzed the impact of COVID-19 vaccination on the survival of solid organ transplant recipients who contracted the disease. The results showed that vaccinated patients had better survival rates, supporting the importance of COVID-19 vaccination in this population.

VACCINES (2022)

Add to Collection

Article Urology & Nephrology

SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients

Aileen X. Wang et al.

Summary: This retrospective analysis found that the treatment with bamlanivimab or casirivimab-imdevimab combined with immunosuppression reduction was well tolerated and associated with favorable clinical outcomes in kidney transplant recipients diagnosed with mild to moderate COVID-19.

KIDNEY360 (2022)

Add to Collection

Letter Immunology

Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

TRANSPLANTATION (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Multidisciplinary Sciences

Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study

Sonsoles Salto-Alejandre et al.

Summary: This study analyzed the characteristics and predictors of unfavorable outcomes in solid organ transplant recipients (SOTRs) with COVID-19. Factors like advanced age, high respiratory rate, lymphopenia, and elevated level of lactate dehydrogenase were identified as independent predictors of ICU admission or death. Early diagnosis of COVID-19 post-transplantation was associated with poorer clinical prognosis.

PLOS ONE (2021)

Add to Collection

Article Immunology

Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients

Michael T. Ou et al.

Summary: The study found that the safety and reactogenicity of SARS-CoV-2 mRNA vaccines in transplant recipients were similar to those reported in the original trials, with rare severe reactions. These early safety data may help reduce vaccine hesitancy among transplant recipients.

TRANSPLANTATION (2021)

Add to Collection

Review Oncology

Propensity score matching with R: conventional methods and new features

Qin-Yu Zhao et al.

Summary: This article discusses the increasing importance of accurately estimating the effects of clinical treatments, as well as the advantages and limitations of propensity score methods in observational studies.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

William A. Werbel et al.

ANNALS OF INTERNAL MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Ilies Benotmane et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Letter Medicine, General & Internal

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

Nassim Kamar et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Immunology

SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19

Brian J. Boyarsky et al.

TRANSPLANTATION (2021)

Add to Collection

Letter Immunology

Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis

Rommel Ravanan et al.

TRANSPLANTATION (2021)

Add to Collection

Article Microbiology

Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom

Jia Wei et al.

Summary: A longitudinal study on 45,965 adults in the UK revealed that older individuals, especially those aged >60 years, had lower antibody levels after a single dose of ChAdOx1 or BNT162b2 COVID-19 vaccines. Prioritizing vaccine allocation for those not previously infected and older individuals for the second dose is recommended based on the findings. Further data is needed to fully understand the relationship between quantitative antibody responses and vaccine-mediated protection.

NATURE MICROBIOLOGY (2021)

Add to Collection

Article Immunology

Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients

Zachary A. Yetmar et al.

Summary: This study retrospectively reviewed solid organ transplant recipients who received monoclonal antibody treatment for COVID-19, showing favorable outcomes and minimal adverse effects in this patient population. Early administration of monoclonal antibody therapy appears to be more efficacious.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Article Immunology

Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant Recipients

Zachary A. Yetmar et al.

Summary: Monoclonal antibody therapy for COVID-19 appears to be safe and effective with favorable outcomes in solid organ transplant recipients, with earlier administration associated with reduced hospitalizations. No episodes of rejection or anaphylaxis were reported.

OPEN FORUM INFECTIOUS DISEASES (2021)

Add to Collection

Article Surgery

COVID-19 in kidney transplant recipients

Vinay Nair et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2020)

Add to Collection

Review Pharmacology & Pharmacy

Immunosuppressive Drugs and COVID-19: A Review

Tessa S. Schoot et al.

FRONTIERS IN PHARMACOLOGY (2020)

Add to Collection

Article Public, Environmental & Occupational Health

COVID-19 mortality risk for older men and women

N. David Yanez et al.

BMC PUBLIC HEALTH (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.